Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast Cancer via Mitophagy
Researchers have found that TSPYL5 promotes paclitaxel resistance in triple-negative breast cancer by stabilizing PINK1 to augment mitophagy.
Researchers have found that TSPYL5 promotes paclitaxel resistance in triple-negative breast cancer by stabilizing PINK1 to augment mitophagy.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.